Newsroom
Search results
Showing matches with:
An Institute Project Recognized in the 2025 Health Research Call by the La Caixa Foundation
20 11 2025
Led by Dr. Albert Quintana, the project proposes an innovative approach to improve the treatment of mitochondrial diseases.
The Oper Doors Day was a success!
18 11 2025
On November 12th, coinciding with Science Week, we held our traditional open house event, with more than a dozen laboratories taking part.
Mitochondrial epilepsy could originate in a specific group of brain neurons
27 10 2025
A team led by Dr Albert Quintana has for the first time identified the mechanism behind a potentially fatal type of epilepsy, a symptom of mitochondrial diseases. The discovery, based on mice models, challenges the traditional idea that these disorders are caused by a generalised energy deficiency and instead reveals a precise disfunction in specific brain circuits.
Manifesto for Brain Research
23 10 2025
The Spanish Society for Neuroscience (SENC) has presented the Manifesto for Brain Research, a call to place Spain at the forefront of the neuroscientific revolution.
The UAB leads Neuroscience research in Spain, according to the BGU ranking
21 10 2025
In the 11th edition of the Best Global Universities (BGU) ranking, published by U.S. News & World Report, the UAB ranks as the number 1 institution in Spain for neuroscience research and 52nd in the world.
Looking for volunteers to participate in a Neuroscience study
15 10 2025
AnderoLab is looking for volunteers to participate in a study investigating how sex, the menstrual cycle, and hormonal levels influence emotional memory modulation. If you are interested, please, fill in the form.
The 2025 conference was a great success!
09 10 2025
Once again, we held our scientific meeting, bringing together 150 participants in Sant Feliu de Guíxols.
A new edition of the Master's in Neuroscience begins.
15 09 2025
Last week, a new edition of the Institute’s Master’s in Neuroscience started, with X students, under the coordination of Dr. Clara Penas.
FDA grants orphan drug designation to INc-developed gene therapy for ALS
06 08 2025
The treatment, licensed to Klotho Neurosciences, is based on a technology developed at the Institute.
Honorable Mention in the UAB Argó Awards
30 07 2025
Two students from Institut Les Vinyes have received an Honorable Mention in the 2025 Argó Awards from the UAB for their research project, developed in collaboration with the research group led by Dr. Lydia Giménez-Llort.